Cargando…
Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
Severe refractory asthma (SRA) still has a high economic and social impact, including a reduction in quality of life (QoL), productivity, a greater risk of exacerbations and emergency department (ED) visits. Another major issue is the need of oral corticosteroids (OCS), often due to a poor response...
Autores principales: | Menzella, Francesco, Ruggiero, Patrizia, Ghidoni, Giulia, Fontana, Matteo, Bagnasco, Diego, Livrieri, Francesco, Scelfo, Chiara, Facciolongo, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490042/ https://www.ncbi.nlm.nih.gov/pubmed/32982318 http://dx.doi.org/10.2147/JAA.S258594 |
Ejemplares similares
-
Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021) -
Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021) -
Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021) -
The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021) -
Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)